Paloma Partners’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-17,924
Closed -$208K 529
2024
Q3
$208K Buy
+17,924
New +$208K 0.01% 692
2016
Q3
Sell
-2,905
Closed -$27K 1503
2016
Q2
$27K Buy
+2,905
New +$27K ﹤0.01% 1679